Insider Trading November 19, 2026 01:30 AM

Morningstar's Mansueto Offloads $1.8 Million in Shares Near 52-Week High

Executive Chairman Joseph Mansueto sells 7,250 shares under a pre-arranged trading plan as the stock hovers close to its peak.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
MORN

Joseph D. Mansueto, Executive Chairman of Morningstar, Inc. (NASDAQ: MORN), sold 7,250 shares of company stock on November 16, 2026, for approximately $1.8 million. The sales were executed under a Rule 10b5-1 trading plan adopted on June 8, 2026, with share prices ranging from $246.8944 to $249.9062. The transaction occurred as Morningstar shares trade near their 52-week high of $251.04, following a 39% gain over the past six months. Despite the stock's strong run, an analysis cited in the report suggests the shares remain undervalued, with the company's market capitalization at $8.82 billion. After the sales, Mansueto directly holds 8,550,794 shares and indirectly beneficially owns 5,600,034 shares through grantor retained annuity trusts and an additional 150,000 shares in trusts for his children.

Morningstar's Mansueto Offloads $1.8 Million in Shares Near 52-Week High
MORN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive Chairman Joseph Mansueto sold 7,250 Morningstar shares for about $1.8 million under a Rule 10b5-1 plan adopted in June 2026.
  • The sale occurred near the stock's 52-week high of $251.04, after a 39% gain over six months, yet an analysis cited in the filing suggests shares remain undervalued.
  • Mansueto retains significant ownership: 8,550,794 direct shares and over 5.75 million indirectly held through trusts.

Morningstar, Inc. (NASDAQ: MORN) Executive Chairman Joseph D. Mansueto has trimmed his stake in the financial services firm, selling 7,250 shares of common stock on November 16, 2026, according to a regulatory filing. The transaction was valued at approximately $1.8 million, with individual sale prices spanning from $246.8944 to $249.9062 per share.

The sale was conducted pursuant to a Rule 10b5-1 trading plan that Mansueto adopted on June 8, 2026. Such plans allow company insiders to set up predetermined schedules for buying or selling shares, providing a defense against allegations of trading on material nonpublic information.

The disposal comes as Morningstar's stock trades close to its 52-week high of $251.04. Shares have rallied 39% over the past six months, a performance that has drawn attention to the company's valuation. According to an analysis referenced in the filing, the stock appears undervalued at current levels, even after the strong run. Morningstar's market capitalization stands at $8.82 billion.

Following the transactions, Mansueto directly holds 8,550,794 shares of Morningstar common stock. In addition, he indirectly beneficially owns 5,600,034 shares through grantor retained annuity trusts, where he serves as trustee for his benefit and that of his children. A further 150,000 shares are held indirectly in trusts for the benefit of his children, with his spouse acting as trustee.

The sale represents a small fraction of Mansueto's overall holdings, which include both direct and indirect positions. Insider transactions are closely monitored by investors for signals about management's confidence in the company's prospects. However, sales made under pre-arranged 10b5-1 plans are often scheduled in advance and may not reflect a change in an executive's view of the business.

Morningstar, known for its investment research and data services, has seen its shares climb steadily over the past six months. The stock's advance has outpaced the broader market, though the filing does not provide comparative index performance. The company's market value of $8.82 billion places it among the larger players in the financial data and analytics space.

Investors will continue to watch insider activity for further clues about the company's trajectory. The filing did not disclose any additional details about Mansueto's plans for his remaining holdings.

Risks

  • Insider sales, even under pre-arranged plans, can be interpreted by some investors as a lack of confidence, potentially pressuring the stock price in the near term.
  • The stock's sharp six-month rally may make it vulnerable to profit-taking, especially if broader market conditions shift or if the valuation analysis proves overly optimistic.
  • Concentration of ownership in trusts could complicate future estate planning or lead to further sales, though no such plans have been disclosed.

More from Insider Trading

VSE Corp CEO John Cuomo Offloads $338,964 in Stock Under Pre-Arranged Plan Nov 19, 2026 Motorsport Games CFO Peter Hansen-Chambers Discloses $9,793 Share Purchase Nov 19, 2026 Peoples Bancorp Director Adds 200 Shares in Open-Market Purchase Nov 19, 2026 Atara Bio CEO Offloads $39,368 in Shares to Cover Tax Bill Nov 19, 2026 CorMedix Director Myron Kaplan Discloses $122,000 Open-Market Share Purchase Nov 19, 2026